We are live on ! Find out more
NEOS

Neos Therapeutics, Inc
NEOS

Delisted

NEOS was delisted on the 19th of March, 2021.

Back to rankings

Fund managers haven’t disclosed any holdings of NEOS yet.

NEOS Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Neos Therapeutics, Inc (NEOS) for Q1 2021, worth a combined $0 — down 100% from $6.45M a quarter earlier.

Sellers outnumbered buyers: 36 funds closed out of NEOS and 0 opened new positions — a net loss of 36 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Stonepine Capital Management, exiting entirely with an estimated $3.1M sold.

  • 0 institutional investors held Neos Therapeutics, Inc (NEOS) as of Q1 2021, down from 37 in Q4 2020.
  • Funds reported $0 of Neos Therapeutics, Inc stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Neos Therapeutics, Inc positions in Q1 2021 and 36 closed out, a net change of -36 holders.
  • The largest Neos Therapeutics, Inc seller in Q1 2021 was Stonepine Capital Management, an estimated $3.1M sold.

Based on aggregated 13F filings for Q1 2021.